iSpecimen (ISPC) Equity Average (2020 - 2026)

iSpecimen's Equity Average history runs 7 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Equity Average fell 21.63% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 21.63% YoY), while the FY2025 annual figure was $3.2 million, down 50.97% from the prior year.
• Equity Average was $2.0 million for Q1 2026 at iSpecimen, down from $3.1 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $28.7 million in Q1 2022 to a low of $1.1 million in Q2 2025.
• Historically, Equity Average has averaged $11.5 million across 5 years, with a median of $8.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Equity Average jumped 357.86% in 2022, then sank 82.25% in 2025.
• A 5-year view of Equity Average shows it stood at $21.4 million in 2022, then slumped by 47.47% to $11.2 million in 2023, then tumbled by 64.25% to $4.0 million in 2024, then slipped by 23.23% to $3.1 million in 2025, then tumbled by 36.66% to $2.0 million in 2026.
• The last three Equity Average figures came in at $2.0 million (Q1 2026), $3.1 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.